“The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results from the CIMPACT Trial” (2019) SKIN The Journal of Cutaneous Medicine, 3(2), p. 174. doi:10.25251/skin.3.2.14.